Pelthos Therapeutics Secures Up to $50MM Senior Secured Term Loan Facility from Horizon Technology Finance
Pelthos Therapeutics, a biopharmaceutical company committed to commercializing innovative therapeutic products for unmet patient needs, secured financing from Horizon Technology Finance, an affiliate of Monroe Capital, with an initial funding of $30 million, and up to $20 million to support...
Read moreDetails










